Medications

Pfizer stock trades halted over drug patent ruling

A U.S. court on Wednesday invalidated the key patent for one of Pfizer's most lucrative medicines, potentially opening the door for cheaper generic versions 18 months sooner than expected and cutting into the drugmaker's ...

Overweight & Obesity

New drug candidate reverses obesity in mice

Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells' mitochondria. A study published in Nature Metabolism shows that a specific class of drugs that block ...

Vaccination

EU lawmakers back COVID vaccines patent waiver

The European Parliament has urged the EU to back a push for a temporary waiver of coronavirus vaccine patents, in the face of scepticism from Brussels and key member states.

Vaccination

WHO boss says vaccine IP waiver not a property 'snatch'

The World Health Organization on Wednesday sought to reassure pharmaceutical companies that a proposal to suspend patent rights on COVID-19 vaccines was not a bid to "snatch" their intellecutual property rights.

Other

Court overturns $482M patent decision against J&J

(AP)—A federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company.

Surgery

Fascia lata can substitute for nasal lining in reconstruction

(HealthDay)—Fascia lata, which is a thin, pliable, and vascularized tissue, can be effectively used as a substitute for nasal lining in complex total and subtotal nasal reconstruction procedures, according to a case series ...

Medications

Bayer vows to fight for patent on anti-cancer drug in India

German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.

Genetics

3Qs: Supreme Court rules human genes can't be patented

The U.S. Supreme Court ruled in a unanimous decision Thursday that naturally occurring human genes can't be patented. The case centered on Myriad Genetics Inc.'s patents on popular breast and ovarian cancer tests. These tests ...

page 22 from 26